These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13638)

  • 1. Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):96-100. PubMed ID: 13638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
    Scena MR
    Cent Afr J Med; 1988 Nov; 34(11):264-8. PubMed ID: 3252975
    [No Abstract]   [Full Text] [Related]  

  • 4. Human sleeping sickness in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):88-95. PubMed ID: 13637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
    Haller L; Adams H; Merouze F; Dago A
    Am J Trop Med Hyg; 1986 Jan; 35(1):94-9. PubMed ID: 3946740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
    Foulkes JR
    J Trop Med Hyg; 1975 Apr; 78(4):72-4. PubMed ID: 1152100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications observed in the treatment of trypanosomiasis in the Congo].
    Ginoux PY; Bissadidi N; Frezil JL
    Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
    Ancelle T; Barret B; Flachet L; Moren A
    Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Mpia B; Ethier L; Mansinsa D
    Lancet; 1989 Jun; 1(8649):1246-50. PubMed ID: 2566790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.
    Adams JH; Haller L; Boa FY; Doua F; Dago A; Konian K
    Neuropathol Appl Neurobiol; 1986; 12(1):81-94. PubMed ID: 3703156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
    Veeken HJ; Ebeling MC; Dolmans WM
    Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual course of west African trypanosomiasis in a Caucasian man.
    Grau Junyent JM; Rozman M; Corachán M; Estruch R; Urbano-Marquez A
    Trans R Soc Trop Med Hyg; 1987; 81(6):931-2. PubMed ID: 3503413
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
    Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic arsenic-induced Guillain-Barré-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study.
    Gherardi RK; Chariot P; Vanderstigel M; Malapert D; Verroust J; Astier A; Brun-Buisson C; Schaeffer A
    Muscle Nerve; 1990 Jul; 13(7):637-45. PubMed ID: 2167451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
    Arroz JO
    Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
    Bales JD; Harrison SM; Mbwabi DL; Schecter PJ
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():111-4. PubMed ID: 2515816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.